NAS:CGEN (Israel)  
Compugen Ltd logo

Compugen Ltd

$ 0.68 -0.0165 (-2.35%) 04:00 PM EST
P/E:
At Loss
P/B:
0.66
Market Cap:
$ 58.74M
Enterprise V:
$ -34.66M
Volume:
675.64K
Avg Vol (2M):
1.37M
Also Trade In:
Volume:
675.64K
Market Cap $:
58.74M
PE Ratio:
At Loss
Avg Vol (2-Month):
1.37M
Enterprise Value $:
-34.66M
PB Ratio:
0.66
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its innovative immuno-oncology pipeline consists of four clinical stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902, bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
Name Current Vs Industry Vs History
Cash-To-Debt 46.02
Equity-to-Asset 0.82
Debt-to-Equity 0.02
Debt-to-EBITDA -0.06
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -3.77
Distress
Grey
Safe
Beneish M-Score -1.93
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 30.15
9-Day RSI 23.52
14-Day RSI 22.21
6-1 Month Momentum % -65.45
12-1 Month Momentum % -80.9

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.29
Quick Ratio 7.29
Cash Ratio 6.93
Days Sales Outstanding 365
Days Payable 1535.86

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -13

Financials (Next Earnings Date:2022-11-11 Est.)

CGEN's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:CGEN

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 6
EPS (TTM) ($) -0.39
Beta 2.06
Volatility % 54.92
14-Day RSI 22.21
14-Day ATR ($) 0.068289
20-Day SMA ($) 0.898685
12-1 Month Momentum % -80.9
52-Week Range ($) 0.657 - 7.48
Shares Outstanding (Mil) 86.62

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Compugen Ltd Filings

Document Form Filing Date
No Filing Data

Compugen Ltd Analysis

Share your research

Headlines

See More
No news.